Relapsing-remitting multiple sclerosis and Blood urea decreased

Summary:

Blood urea decreased is found among people with Relapsing-remitting multiple sclerosis, especially for people who are female, 50-59 old.

The study analyzes which people have Blood urea decreased with Relapsing-remitting multiple sclerosis. It is created by eHealthMe based on reports of 15 people who have Relapsing-remitting multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Relapsing-remitting multiple sclerosis?

Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged) is found to be associated with 126 drugs and 178 conditions by eHealthMe. Check the latest studies of Relapsing-remitting multiple sclerosis.

What is Blood urea decreased?

Blood urea decreased is found to be associated with 347 drugs and 485 conditions by eHealthMe. Check the latest studies of Blood urea decreased.



On Jul, 19, 2026

15 people who have Relapsing-Remitting Multiple Sclerosis and Blood Urea Decreased are studied.

Would you have Blood urea decreased when you have Relapsing-remitting multiple sclerosis?

Gender of people who have Relapsing-Remitting Multiple Sclerosis and experienced Blood Urea Decreased *:

  • female: 80 %
  • male: 20 %

Age of people who have Relapsing-Remitting Multiple Sclerosis and experienced Blood Urea Decreased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 13.33 %
  • 40-49: 20.0 %
  • 50-59: 60.0 %
  • 60+: 6.67 %

Common co-existing conditions for these people *:

  1. Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 6 people, 40.00%
  2. Insomnia (sleeplessness): 6 people, 40.00%
  3. Chest Pain: 6 people, 40.00%
  4. Dehydration (dryness resulting from the removal of water): 6 people, 40.00%
  5. Electrolyte Imbalance: 6 people, 40.00%
  6. Fever: 6 people, 40.00%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 40.00%
  8. Headache (pain in head): 6 people, 40.00%
  9. Migraine (headache): 6 people, 40.00%
  10. Nausea (feeling of having an urge to vomit): 6 people, 40.00%

Common drugs taken by these people *:

  1. Zofran: 6 people, 40.00%
  2. Ofirmev: 6 people, 40.00%
  3. Cambia: 6 people, 40.00%
  4. Cathflo Activase: 6 people, 40.00%
  5. Cleocin: 6 people, 40.00%
  6. Dilaudid: 6 people, 40.00%
  7. Duragesic: 6 people, 40.00%
  8. Eliquis: 6 people, 40.00%
  9. Gilenya: 6 people, 40.00%
  10. Heparin: 6 people, 40.00%

Common symptoms for these people *:

  1. Lymphocyte Count Decreased: 15 people, 100.00%
  2. Thrombocytopenia (decrease of platelets in blood): 12 people, 80.00%
  3. Blood Glucose Increased: 9 people, 60.00%
  4. Hypotension (abnormally low blood pressure): 9 people, 60.00%
  5. Blood Creatine Phosphokinase Increased: 7 people, 46.67%
  6. Abdominal Wall Haematoma (abdominal wall blood clotting): 6 people, 40.00%
  7. Carbon Dioxide Decreased: 6 people, 40.00%
  8. Iron Deficiency Anaemia: 6 people, 40.00%
  9. Jugular Vein Thrombosis (clot in jugular vein): 6 people, 40.00%
  10. Leukopenia (less number of white blood cells in blood): 6 people, 40.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Blood urea decreased?

- Check whether Blood urea decreased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Blood urea decreased:

All the conditions that are associated with Blood urea decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Blood urea decreased and Relapsing-remitting multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: